Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Bukhari

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Rheumatology Advances in Practice|October 21, 2022
Frailty assessment in ANCA-associated vasculitis: current evidence and remaining uncertaintiesChoon Ying Wang, Henry H L Wu, Quinta Ashcroft, et al.
Rheumatology Advances in Practice|November 29, 2023
How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation surveyJames A Prior, Edward Roddy, Ivonne Solis-Trapala, et al.
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
Rheumatology (Oxford, England)|March 24, 2010
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapyChris Deighton, Kimme Hyrich, Tina Ding, et al.
Rheumatology (Oxford, England)|March 24, 2010
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapyChris Deighton, Kimme Hyrich, Tina Ding, et al.
Rheumatology (Oxford, England)|July 15, 2021
Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosisItalo Marago, Mark Roberts, Federico Roncaroli, et al.
Rheumatology (Oxford, England)|May 7, 2011
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritisMarwan Bukhari, Rikki Abernethy, Chris Deighton, et al.
Rheumatology (Oxford, England)|September 15, 2010
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapiesTina Ding, Jo Ledingham, Raashid Luqmani, et al.
Rheumatology (Oxford, England)|September 22, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summaryChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Rheumatology Advances in Practice|October 21, 2022
Frailty assessment in ANCA-associated vasculitis: current evidence and remaining uncertaintiesChoon Ying Wang, Henry H L Wu, Quinta Ashcroft, et al.
Rheumatology Advances in Practice|November 29, 2023
How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation surveyJames A Prior, Edward Roddy, Ivonne Solis-Trapala, et al.
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
Rheumatology (Oxford, England)|March 24, 2010
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapyChris Deighton, Kimme Hyrich, Tina Ding, et al.
Rheumatology (Oxford, England)|March 24, 2010
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapyChris Deighton, Kimme Hyrich, Tina Ding, et al.
Rheumatology (Oxford, England)|July 15, 2021
Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosisItalo Marago, Mark Roberts, Federico Roncaroli, et al.
Rheumatology (Oxford, England)|May 7, 2011
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritisMarwan Bukhari, Rikki Abernethy, Chris Deighton, et al.
Rheumatology (Oxford, England)|September 15, 2010
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapiesTina Ding, Jo Ledingham, Raashid Luqmani, et al.
Rheumatology (Oxford, England)|September 22, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritisChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Rheumatology (Oxford, England)|August 24, 2018
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summaryChristopher R Holroyd, Rakhi Seth, Marwan Bukhari, et al.
Pageof 8